1606 Corp. AI Chatbots Innovations, Highlights Adnexus LOI, and Quarterly Reporting Update After Q3 Filling
1606 Corp. (OTC PINK:CBDW) reports progress in Q3 2024, focusing on AI chatbot market expansion and strategic partnerships. The company has filed its 10-Q for Q3 2024, maintaining current SEC filing status. Key developments include signing a Letter of Intent with Adnexus Biotechnologies for potential strategic investment in AI and biotechnology solutions. The company has created two chatbots (available at cbdw.ai) and plans to expand into e-commerce, finance, healthcare, and telecommunications sectors. Future focus includes closing the Adnexus investment, launching additional AI chatbot solutions, and expanding market presence.
1606 Corp. (OTC PINK:CBDW) riporta progressi nel terzo trimestre del 2024, concentrandosi sull'espansione del mercato dei chatbot AI e su partnership strategiche. L'azienda ha presentato il suo 10-Q per il terzo trimestre del 2024, mantenendo lo stato attuale di filing SEC. Gli sviluppi chiave includono la firma di una Lettera di Intenti con Adnexus Biotechnologies per un potenziale investimento strategico in soluzioni di AI e biotecnologia. L'azienda ha creato due chatbot (disponibili su cbdw.ai) e prevede di espandersi nei settori dell'e-commerce, finanza, sanità e telecomunicazioni. Il focus futuro include la conclusione dell'investimento con Adnexus, il lancio di ulteriori soluzioni di chatbot AI e l'espansione della presenza sul mercato.
1606 Corp. (OTC PINK:CBDW) informa sobre los avances en el tercer trimestre de 2024, centrándose en la expansión del mercado de chatbots de IA y asociaciones estratégicas. La compañía ha presentado su 10-Q para el tercer trimestre de 2024, manteniendo el estado actual de presentación ante la SEC. Los desarrollos clave incluyen la firma de una Carta de Intención con Adnexus Biotechnologies para una posible inversión estratégica en soluciones de IA y biotecnología. La compañía ha creado dos chatbots (disponibles en cbdw.ai) y planea expandirse en los sectores de comercio electrónico, finanzas, atención médica y telecomunicaciones. El futuro enfoque incluye cerrar la inversión con Adnexus, lanzar soluciones adicionales de chatbots de IA y expandir la presencia en el mercado.
1606 Corp. (OTC PINK:CBDW)는 2024년 3분기에 대한 진행 상황을 보고하면서 AI 챗봇 시장 확장 및 전략적 파트너십에 중점을 두고 있습니다. 이 회사는 2024년 3분기 10-Q를 제출했습니다고, 현재 SEC 제출 상태를 유지하고 있습니다. 주요 발전 사항으로는 AI 및 생명공학 솔루션에 대한 잠재적 전략적 투자를 위해 Adnexus Biotechnologies와의 의향서 서명이 포함됩니다. 이 회사는 두 개의 챗봇을 만들었으며(cbdw.ai에서 이용 가능) 전자상거래, 금융, 헬스케어, 통신 분야로 확장할 계획입니다. 향후 초점은 Adnexus 투자 마무리, 추가 AI 챗봇 솔루션 출시, 시장 존재감 확대를 포함합니다.
1606 Corp. (OTC PINK:CBDW) fait état des progrès réalisés au troisième trimestre 2024, en se concentrant sur l'expansion du marché des chatbots IA et les partenariats stratégiques. L'entreprise a dépôt son 10-Q pour le troisième trimestre 2024, maintenant le statut de dépôt actuel auprès de la SEC. Les développements clés incluent la signature d'une lettre d'intention avec Adnexus Biotechnologies pour un investissement stratégique potentiel dans les solutions d'IA et de biotechnologie. L'entreprise a créé deux chatbots (disponibles sur cbdw.ai) et prévoit de s'étendre dans les secteurs du commerce électronique, des finances, de la santé et des télécommunications. L'accent futur sera mis sur la conclusion de l'investissement avec Adnexus, le lancement de nouvelles solutions de chatbots IA et l'expansion de la présence sur le marché.
1606 Corp. (OTC PINK:CBDW) berichtet über Fortschritte im dritten Quartal 2024 und fokussiert sich auf die Expansion des Marktes für AI-Chatbots sowie strategische Partnerschaften. Das Unternehmen hat seinen 10-Q für das dritte Quartal 2024 eingereicht und den aktuellen SEC-Filing-Status beibehalten. Zu den wichtigsten Entwicklungen gehört die Unterzeichnung eines Absichtsschreibens mit Adnexus Biotechnologies für eine potenzielle strategische Investition in AI- und biotechnologische Lösungen. Das Unternehmen hat zwei Chatbots erstellt (verfügbar unter cbdw.ai) und plant, in die Bereiche E-Commerce, Finanzen, Gesundheitswesen und Telekommunikation zu expandieren. Der zukünftige Fokus liegt auf dem Abschluss der Adnexus-Investition, der Einführung zusätzlicher AI-Chatbot-Lösungen und der Erweiterung der Marktpräsenz.
- Maintained current SEC filing status with successful Q3 2024 10-Q submission
- Signed strategic LOI with Adnexus Biotechnologies for AI and biotech expansion
- Successfully developed and deployed two operational chatbots
- None.
SEATTLE, WA / ACCESSWIRE / November 19, 2024 / 1606 Corp. (OTC PINK:CBDW) (the "Company," or "1606") has made strong progress in the latest quarter, positioning itself as a key player in the growing AI chatbot market. The Company has focused on expanding its product offerings, forging strategic partnerships, and investing in innovative AI technology that enhances user interactions across industries. A key milestone for the Q3 includes strategic partnerships with Adnexus, marking a significant leap in the Company's AI-driven solutions.
Key Developments:
Quarterly SEC reporting:
We are excited to announce that we have filed our 10-Q for the quarter ended September 30, 2024. This filing reflects our commitment to transparency and regulatory compliance, providing investors and shareholders with detailed insights into our financial performance and operational activities. We are proud that we have been able to stay current with all fillings since our inception three years ago.
Expansion of Market Reach:
Throughout the quarter, we made substantial efforts to increase our market reach into the rapidly growing demand for AI-driven customer service and automation tools. We are committed to exploring new opportunities for expansion, particularly in sectors such as e-commerce, finance, healthcare, and telecommunications, where AI-powered chatbots are increasingly in demand. We have already created two chatbots that can be tested at cbdw.ai
Ongoing AI Innovation and Product Development:
Innovation remains at the core of our strategy, with a continuous focus on improving our AI chatbot capabilities. By integrating more advanced machine learning models and NLP techniques, we aim to provide highly personalized, human-like interactions for businesses and consumers alike.
Strategic Partnership with Adnexus Biotechnologies:
We signed a Letter of Intent (LOI) with Adnexus Biotechnologies, a leading firm in AI and biotechnology solutions. This potential strategic investment underscores our commitment to expanding our technological footprint and enhancing our capabilities in the rapidly evolving field of AI. We believe the integration of Adnexus's cutting-edge AI research and development expertise would significantly bolster our portfolio, bringing advanced solutions to the intersection of artificial intelligence and healthcare and biotech.
CEO Statement
Austen Lambrecht, CEO of 1606 Corp., commented, "This has been a transformative quarter for 1606 Corp. With the successful filing of our third consecutive Quarterly Report, we continue to demonstrate our commitment to transparency and regulatory compliance. A key milestone for Q3 was the signing of our Letter of Intent with Adnexus Biotechnologies, which opens exciting new opportunities in the AI sector." Lambrechht continued, "We're building a strong foundation for long-term growth by expanding our technological capabilities and forging strategic partnerships. I'm incredibly proud of our team's progress and look forward to further advancing our mission of innovation and excellence in the months ahead."
Outlook for the Next Quarter:
Looking ahead, 1606 Corp's focus will be on:
Closing Strategic Investment with Adnexus: We will be focused on closing the investment in Adnexus Biotechnologies.
Expanding AI Chatbot Solutions: We will continue to enhance our AI capabilities, with plans to launch additional AI-powered chatbot solutions that offer businesses even more advanced tools for automation, customer service, and engagement.
Growing Market Presence: Through the partnership with Adnexus, we aim to expand our reach into new verticals, such as healthcare, finance, and telecommunications, where AI chatbots are rapidly becoming essential for operational efficiency.
Increased Revenue from AI Chatbots: As AI solutions like Chat IR gain traction, we expect to see a rise in demand for our products, which we believe will contribute to revenue growth in the next quarter.
About 1606 Corp.
1606 Corp. stands at the forefront of technological innovation, particularly in AI Chatbots. Our mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. We are dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.
As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction.
For more information, please visit cbdw.ai.
Industry Information
The global AI market, valued at
Forward-Looking Statements
This press release includes forward-looking statements under federal securities laws, including projections and expectations regarding business developments, operations, and market conditions. These statements are identified by terms such as "should," "may," "intends," "anticipates," and others. While based on reasonable assumptions, results may differ due to various risks and uncertainties. Please review cautionary statements and disclosures in our filings with the SEC. The Company does not undertake any obligation to update forward-looking statements except as required by law.
Contact Information
Austen Lambrecht
CEO
austen@1606corp.com
SOURCE: 1606 Corp
View the original press release on accesswire.com
FAQ
What is the status of 1606 Corp's (CBDW) Q3 2024 SEC filing?
What strategic partnership did 1606 Corp (CBDW) announce in Q3 2024?
How many AI chatbots has 1606 Corp (CBDW) developed as of Q3 2024?
What are 1606 Corp's (CBDW) expansion plans following Q3 2024?
